TIAA CREF Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

TIAA CREF Investment Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4	Closed	–	–	3074
2017 Q4	$0	Sell	4 -23,581	-100%	-$2.59M	﹤0.01%	3072
2017 Q3	$2.66M	Buy	23,585 +1,136	+5%	+$124K	﹤0.01%	2005
2017 Q2	$2.52M	Sell	22,449 -3,234	-13%	-$365K	﹤0.01%	2048
2017 Q1	$3M	Buy	25,683 +2,606	+11%	+$288K	﹤0.01%	1901
2016 Q4	$2.43M	Buy	23,077 +366	+2%	+$38.3K	﹤0.01%	2076
2016 Q3	$2.51K	Sell	22,711 -1,182	-5%	-$157K	﹤0.01%	2052
2016 Q2	$3.48M	Buy	23,893 +8,073	+51%	+$1.14M	﹤0.01%	1784
2016 Q1	$2.27M	Sell	15,820 -1,376	-8%	-$195K	﹤0.01%	1999
2015 Q4	$2.66M	Buy	+17,196	New	+$2.51M	﹤0.01%	1991

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TIAA CREF Investment Management's TARO Position: Q1 2018 in Review

TIAA CREF Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2018, closing a stake of 4 shares.

TIAA CREF Investment Management first reported a position in TARO in Q4 2015 and held it in 9 quarters. The position peaked at $3.48M in Q2 2016. 109 funds tracked by Wall St. Rank hold TARO as of Q1 2018.

TIAA CREF Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2018 after selling out during the quarter.
TIAA CREF Investment Management sold 4 Taro Pharmaceutical Industries Ltd. shares in Q1 2018.
TIAA CREF Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 9 quarters.
TIAA CREF Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $3.48M in Q2 2016.
109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2018.

Based on TIAA CREF Investment Management's 13F filing for Q1 2018, filed 14 May 2018.